Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) Operating Expenses (2016 - 2025)

Utah Medical Products has reported Operating Expenses over the past 16 years, most recently at $772000.0 for Q4 2025.

  • Quarterly results put Operating Expenses at $772000.0 for Q4 2025, up 56.91% from a year ago — trailing twelve months through Dec 2025 was $8.5 million (down 1.16% YoY), and the annual figure for FY2025 was $8.5 million, down 1.16%.
  • Operating Expenses for Q4 2025 was $772000.0 at Utah Medical Products, down from $3.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for UTMD hit a ceiling of $3.4 million in Q1 2023 and a floor of $492000.0 in Q4 2024.
  • Median Operating Expenses over the past 5 years was $2.9 million (2021), compared with a mean of $2.5 million.
  • Biggest five-year swings in Operating Expenses: crashed 66.51% in 2024 and later surged 56.91% in 2025.
  • Utah Medical Products' Operating Expenses stood at $1.6 million in 2021, then grew by 11.54% to $1.8 million in 2022, then fell by 16.06% to $1.5 million in 2023, then crashed by 66.51% to $492000.0 in 2024, then surged by 56.91% to $772000.0 in 2025.
  • The last three reported values for Operating Expenses were $772000.0 (Q4 2025), $3.0 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.